We studied the usefulness of the excision repair cross-complementing 1 (ERCC1), xeroderma pigmentosum group D (XPD), XRCC1 and GSTP1 polymorphisms as predictors of clinical outcome in these patients. The gene discussed is XRCC1; the disease is xeroderma pigmentosum-Cockayne syndrome complex.